Merck (NYSE:MRK) received expanded EU approval for KEYTRUDA-based regimens in platinum-resistant ovarian cancer, making it ...
Fluphenazine (Anatensol Decanoate) is a tranquilizer, prescribed for mental retardation.It belongs to the piperazine class of phenothiazines. The information provided on this page is intended to serve ...
DUBLIN--(BUSINESS WIRE)--The "Global and Chinese Isoamyl Decanoate Industry, 2018 Market Research Report" report has been added to ResearchAndMarkets.com's offering. This report provides key ...
Details concerning the Testosterone Decanoate combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, ...
Merck, known as MSD outside of the United States and Canada, announced positive topline results from the phase 3 CORALreef Lipids trial evaluating the safety and efficacy of enlicitide decanoate, an ...
Fluphenazine decanoate 25mg/mL; syringe; vial; contains benzyl alcohol. Cardiovascular or renal disease. Pheochromocytoma. Seizures. Glaucoma. History of breast cancer. Exposure to extreme heat or ...
A phase II study to evaluate the effects of docetaxel plus lycopene in advanced castrate-resistant prostate cancer. Rucaparib plus enzalutamide in patients (pts) with metastatic castration-resistant ...
PSMAddition: A phase 3 trial to compare treatment with 177Lu-PSMA-617 plus standard of care (SoC) and SoC alone in patients with metastatic hormone-sensitive prostate cancer. Phase III study of local ...
RAHWAY, N.J.--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results